Literature DB >> 17211138

Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier.

Luying Peng1, Zhenjuan He, Wei Chen, Ian R Holzman, Jing Lin.   

Abstract

Production of short-chain fatty acids (SCFA) in the intestinal lumen may play an important role in the maintenance of the intestinal barrier. However, overproduction/accumulation of SCFA in the bowel may be toxic to the intestinal mucosa and has been hypothesized to play a role in the pathogenesis of neonatal necrotizing enterocolitis (NEC). By using a Caco-2 cell monolayer model of intestinal barrier, we report here that the effect of butyrate on the intestinal barrier is paradoxical. Butyrate at a low concentration (2 mM) promotes intestinal barrier function as measured by a significant increase in transepithelial electrical resistance (TER) and a significant decrease in inulin permeability. Butyrate at a high concentration (8 mM) reduces TER and increases inulin permeability significantly. Butyrate induces apoptosis and reduces the number of viable Caco-2 cells in a dose-dependent manner. Intestinal barrier function impairment induced by high concentrations of butyrate is most likely related to butyrate-induced cytotoxicity due to apoptosis. We conclude that the effect of butyrate on the intestinal barrier is paradoxical; i.e. whereas low concentrations of butyrate may be beneficial in promoting intestinal barrier function, excessive butyrate may induce severe intestinal epithelial cell apoptosis and disrupt intestinal barrier.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17211138     DOI: 10.1203/01.pdr.0000250014.92242.f3

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  140 in total

1.  Oral supplementation of butyrate reduces mucositis and intestinal permeability associated with 5-Fluorouracil administration.

Authors:  Talita Mayra Ferreira; Alda Jusceline Leonel; Marco Antônio Melo; Rosana R G Santos; Denise Carmona Cara; Valbert N Cardoso; Maria I T D Correia; Jacqueline I Alvarez-Leite
Journal:  Lipids       Date:  2012-05-31       Impact factor: 1.880

Review 2.  Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation.

Authors:  Tessa M Andermann; Andrew Rezvani; Ami S Bhatt
Journal:  Curr Hematol Malig Rep       Date:  2016-02       Impact factor: 3.952

Review 3.  Microbiome-intestine cross talk during acute graft-versus-host disease.

Authors:  Hind Rafei; Robert R Jenq
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

Review 4.  The role of the gut microbiome in systemic inflammatory disease.

Authors:  Jose C Clemente; Julia Manasson; Jose U Scher
Journal:  BMJ       Date:  2018-01-08

5.  T84 monolayers are superior to Caco-2 as a model system of colonocytes.

Authors:  Sarah Devriese; Lien Van den Bossche; Sophie Van Welden; Tom Holvoet; Iris Pinheiro; Pieter Hindryckx; Martine De Vos; Debby Laukens
Journal:  Histochem Cell Biol       Date:  2017-03-06       Impact factor: 4.304

6.  Unveiling an abundant core microbiota in the human adult colon by a phylogroup-independent searching approach.

Authors:  Monika Sekelja; Ingunn Berget; Tormod Næs; Knut Rudi
Journal:  ISME J       Date:  2010-08-26       Impact factor: 10.302

Review 7.  Bacteria in the intestine, helpful residents or enemies from within?

Authors:  Geraldine O Canny; Beth A McCormick
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

Review 8.  Human nutrition, the gut microbiome and the immune system.

Authors:  Andrew L Kau; Philip P Ahern; Nicholas W Griffin; Andrew L Goodman; Jeffrey I Gordon
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

Review 9.  Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

Authors:  Roberto Berni Canani; Margherita Di Costanzo; Ludovica Leone; Monica Pedata; Rosaria Meli; Antonio Calignano
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

10.  Antibiotics-mediated intestinal microbiome perturbation aggravates tacrolimus-induced glucose disorders in mice.

Authors:  Yuqiu Han; Xiangyang Jiang; Qi Ling; Li Wu; Pin Wu; Ruiqi Tang; Xiaowei Xu; Meifang Yang; Lijiang Zhang; Weiwei Zhu; Baohong Wang; Lanjuan Li
Journal:  Front Med       Date:  2019-05-02       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.